Health
FDA Approves Treatment for Chronic Kidney Disease – StreetInsider.com
SILVER SPRING, Md., April 30, 2021 /PRNewswire/ –Â Today, the U.S. Food and Drug Administration approved Farxiga (dapagliflozin) oral tablets to reduce the…
SILVER SPRING, Md., April 30, 2021 /PRNewswire/ – Today, the U.S. Food and Drug Administration approved Farxiga (dapagliflozin) oral tablets to reduce the risk of kidney function decline, kidney failure, cardiovascular death and hospitalization for heart failure in adults with chronic kidney disease who are at risk of disease progression. Â
“Chronic kidney disease is an important public health issue, and there is a significant unmet need for therapies that slow disease progression and improve…
-
General23 hours agoOf saints and sinners | The Spectator Australia
-
General23 hours agoSmall plane crashes into San Diego neighbourhood, setting homes and vehicles on fire
-
Noosa News13 hours agoTully Sugar Mill celebrates 100 years of cane harvesting amid floods and cyclones
-
General23 hours agoWhy the nation needs the Nationals to ditch Net Zero